# A First-in-Human Study of KINE-101 in Healthy Volunteers

> **NCT07343323** · PHASE1 · COMPLETED · sponsor: **Kine Sciences Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** KINE-101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07343323
- **Lead sponsor:** Kine Sciences Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-05
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07343323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07343323, "A First-in-Human Study of KINE-101 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07343323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*